ShorT and OPtimal duration of Dual AntiPlatelet Therapy study
Not Applicable
- Conditions
- coronary artery disease
- Registration Number
- JPRN-UMIN000008878
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have been implanted drug eluting stent other than everolimus-eluting cobalt-chromium stent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method composite endpoint of cardiovascular death in 12 months, myocardial infarction (MI), stroke (ischemic and hemorrhagic), stent thrombosis (Definite stent thrombosis [ST] not resulting in MI) and serious bleeding (TIMI Major/Minor).
- Secondary Outcome Measures
Name Time Method [major secondary endpoint] Cardiovascular death/ MI/ stroke/ definite ST Major bleeding (TIMI Major/ Minor) [secondary endpoint] Death / MI Death Cardiovascular death/ MI Cardiovascular death MI Stroke ST (ARC definition) TLF TVF MACE Any TLR Clinically-driven TLR Non-TLR CABG Any TVR Any revascularization Bleeding complications